https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-07-18 / BMC Cancer 2018 Jul;18(1):746
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-07-18 / BMC Cancer 2018 Jul;18(1):7462018-07-18 00:00:002018-07-18 00:00:00Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-07-12 / 2018 Jul;7(7)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-07-12 / 2018 Jul;7(7)2018-07-12 00:00:002018-07-12 00:00:00Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-07-03 / Front Immunol 2018;9:1534
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-07-03 / Front Immunol 2018;9:15342018-07-03 00:00:002018-07-03 00:00:00Therapeutic Prospects of Extracellular Vesicles in Cancer Treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-07-03 / 2018;9:809
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-07-03 / 2018;9:8092018-07-03 00:00:002018-07-03 00:00:00Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-06-26 / N. Engl. J. Med. 2018 07;379(2):194-196
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-06-26 / N. Engl. J. Med. 2018 07;379(2):194-1962018-06-26 00:00:002019-02-15 09:23:06Exploiting Viruses to Treat Diseases
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-06-26 / N. Engl. J. Med. 2018 07;379(2):150-161
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-06-26 / N. Engl. J. Med. 2018 07;379(2):150-1612018-06-26 00:00:002019-02-15 09:00:21Recurrent Glioblastoma Treated with Recombinant Poliovirus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-06-19 / Oncotarget 2018 Jun;9(47):28702-28716
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-06-19 / Oncotarget 2018 Jun;9(47):28702-287162018-06-19 00:00:002019-02-15 08:36:18Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-06-19 / Clin. Cancer Res. 2018 Oct;24(19):4900-4912
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-06-19 / Clin. Cancer Res. 2018 Oct;24(19):4900-49122018-06-19 00:00:002018-06-19 00:00:00Chemotherapy Sensitizes Therapy-Resistant Cells to Mild Hyperthermia by Suppressing Heat Shock Protein 27 Expression in Triple-Negative Breast Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-06-18 / Cancer Cell Int. 2018;18:85
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-06-18 / Cancer Cell Int. 2018;18:852018-06-18 00:00:002019-02-15 08:46:17Targeting dendritic cells in pancreatic ductal adenocarcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-06-15 / Rep Pract Oncol Radiother 2018 Nov-Dec;23(6):595-603
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-06-15 / Rep Pract Oncol Radiother 2018 Nov-Dec;23(6):595-6032018-06-15 00:00:002019-03-27 10:40:07Hyperthermia in cervical cancer – current status
